We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Concessions Mark Solvay Settlement

Law360 (September 14, 2006, 12:00 AM EDT) -- The U.S. pharmaceutical unit of Belgian chemicals firm Solvay SA has settled a pair of patent-infringement lawsuits with two generic drug makers over a treatment for low testosterone, or “Low T.”

The settlement puts to rest lawsuits filed in August 2003 against generic drug makers Watson Pharmaceuticals Inc. and a partner of Par Pharmaceutical Companies Inc. in the U.S. District Court for the Northern District of Georgia.

The lawsuits were filed by Marietta, Georgia-based Unimed Pharmaceuticals Inc.—a subsidiary of Solvay Pharmaceuticals Inc.—after both defendants filed Abbreviated...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.